# ITACA-S2 (Intergroup Trial in Adjuvant Chemotherapy for Adenocarcinoma of the Stomach)

> **NCT01989858** · PHASE3 · TERMINATED · sponsor: **Mario Negri Institute for Pharmacological Research** · enrollment: 1180 (actual)

## Conditions studied

- Gastric Adenocarcinoma

## Interventions

- **OTHER:** peri-operative cht
- **OTHER:** post-operative CHT
- **OTHER:** peri-operative cht + post-operative cht-rtx
- **OTHER:** post-operative cht + post-operative cht-rtx

## Key facts

- **NCT ID:** NCT01989858
- **Lead sponsor:** Mario Negri Institute for Pharmacological Research
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2010-11
- **Primary completion:** 2013-12
- **Final completion:** 2013-12
- **Target enrollment:** 1180 (ACTUAL)
- **Why stopped:** lack of clinical cases
- **Last updated:** 2015-01-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01989858

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01989858, "ITACA-S2 (Intergroup Trial in Adjuvant Chemotherapy for Adenocarcinoma of the Stomach)". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01989858. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*